Publications found:
73,128
Sort by:
Global Needles Market Size study, by Type (Conventional Needles, Safety Needles) By Product (Suture Needles, Blood Collection Needles, Ophthalmic Needles, Dental Needles, Insufflation Needles, Pen Needles, Other Needles) By Delivery Mode (Hypodermic Needles, Intravenous Needles, Intramuscular Needles, Intraperitoneal Needles) By Material (Glass Needles, Plastic Needles, Stainless Steel/Metallic Needles, Polyetheretherketone (PEEK) Needles) By End User (Hospitals, Diagnostic Centres, Home Healthcare, Other End Users) and Regional Forecasts 2019-2026
US$ 3,000.00
Global Needles Market is valued approximately USD 6.2 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 7.80 % over the forecast period 2019-2026. Needles are utilized...
February 2020
200 pages
Global Operating Room Integration Market Size study, by Component (Software, Services), by Application (General Surgery, Orthopedic Surgery, Cardiovascular Surgery, Neurosurgery, Thoracic Surgery, Others), by End-User (Hospitals, Ambulatory Surgery Centers & Clinics) and Regional Forecasts 2019-2026
US$ 3,000.00
Global Operating Room Integration Market is valued approximately USD 0.88 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 13.5% over the forecast period 2019-2026. W...
February 2020
200 pages
Global Ophthalmic Lasers Market Size study, by Product (Femtosecond Lasers, Excimer Lasers, ND:Yag Lasers, Diode Lasers, Others) By Application (Refractive Error Correction, Cataract Removal, Diabetic Retinopathy Treatment, Glaucoma Treatment, Age-Related Macular Degeneration Treatment, Others) By End User (Hospitals, Specialty Clinics and Ambulatory Surgery Centers) and Regional Forecasts 2019-2026
US$ 3,000.00
Global Ophthalmic Lasers Market is valued approximately USD 1069.6 million in 2018 and is anticipated to grow with a healthy growth rate of more than 5.10 % over the forecast period 2019-2026. Ophthal...
February 2020
200 pages
Global Pen Needles Market Size study, by Type (Standard Pen Needles, Safety Pen Needles) By Length ( 4mm, 5mm, 6mm, 8mm, 10mm, 12mm) By Therapy (Insulin Therapy, Glucagon-Like Peptide-1 (GLP-1) Therapy, Growth Hormone Therapy, Other Therapies) By Mode of Purchase (Retail, Non-Retail) and Regional Forecasts 2019-2026
US$ 3,000.00
Global Pen Needles Market is valued approximately USD 1 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 10.8% over the forecast period 2019-2026. Pen needles are use...
February 2020
200 pages
Global Top 10 Drug Delivery Technologies Market Size study, by Drug Delivery Technologies (Topical, Oral Time Release/Sustained Release, Targeted Delivery, Encapsulation, Aerosol/Inhalation, Transdermal, Implants, Injectable, Liposomal, Pegylation ) and Regional Forecasts 2019-2026
US$ 3,000.00
Global Top 10 Drug Delivery Technologies Market is valued approximately USD 111.5 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 11% over the forecast period 2019-2...
February 2020
200 pages
Global Clinical Risk Grouping Solutions Market Size study, by Product (Scorecards & Visualization Tools, Dashboard Analytics Solutions, Risk Reporting Solutions), by Deployment (Private Cloud, Public Cloud, Hybrid Cloud), by End-User (Hospitals, Payers, Ambulatory Care Centers, Others) and Regional Forecasts 2019-2026
US$ 3,000.00
Global Clinical Risk Grouping Solutions Market is valued approximately at USD 369.70 million in 2018 and is anticipated to grow with a healthy growth rate of more than 15.5% over the forecast period 2...
February 2020
200 pages
Global Vitamins Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
US$ 3,480.00
... 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Vitamins, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze ...
February 2020
102 pages
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline guide also reviews of key players involved in therapeutic development for Uterine Leiomyoma (Uterine Fibroids) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
113 pages
Erectile Dysfunction - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Erectile Dysfunction (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Erectile Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
150 pages
Male Hypogonadism - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Male Hypogonadism (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Male Hypogonadism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
107 pages
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Ventilator Associated Pneumonia (VAP) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Ventilator Associated Pneumonia (VAP) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
176 pages
Amyloidosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Amyloidosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Amyloidosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
226 pages
Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Onychomycosis (Tinea Unguium) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Onychomycosis (Tinea Unguium) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
83 pages
Rheumatoid Arthritis - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Rheumatoid Arthritis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Rheumatoid Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
1156 pages
Smallpox - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Smallpox (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Smallpox and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
81 pages
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Acute Respiratory Distress Syndrome (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Acute Respiratory Distress Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
129 pages
Cholera - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cholera (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cholera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
63 pages
Typhoid Fever - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Typhoid Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Typhoid Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
52 pages
Diabetic Macular Edema - Pipeline Review, H1 2020
US$ 2,000.00
... . The Diabetic Macular Edema (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Macular Edema and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
298 pages
Sarcopenia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Sarcopenia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sarcopenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
91 pages
Anthrax - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Anthrax (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Anthrax and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
110 pages
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Hospital Acquired Pneumonia (HAP) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hospital Acquired Pneumonia (HAP) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
199 pages
Hypoglycemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hypoglycemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypoglycemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
88 pages
Mumps - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Mumps (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Mumps and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
31 pages
Warts - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Warts (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Warts and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
111 pages
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2020
US$ 2,000.00
... . The Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
99 pages
Chemotherapy Induced Neutropenia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chemotherapy Induced Neutropenia (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
146 pages
Insulin Resistance - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Insulin Resistance (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Insulin Resistance and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
51 pages
Bacterial Vaginosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bacterial Vaginosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Vaginosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
72 pages
Degenerative Disc Disease - Pipeline Review, H1 2020
US$ 2,000.00
... . The Degenerative Disc Disease (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Degenerative Disc Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
68 pages
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2020
US$ 2,000.00
... . The Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Peripheral Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
86 pages
Plague - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Plague (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Plague and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
70 pages
Botulism - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Botulism (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Botulism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
36 pages
Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Opioid-Induced Constipation (OIC) (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Opioid-Induced Constipation (OIC) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
53 pages
Lyme Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Lyme Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lyme Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
59 pages
Streptococcus pyogenes Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Streptococcus pyogenes Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Streptococcus pyogenes Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
35 pages
Community Acquired Pneumonia - Pipeline Review, H1 2020
US$ 2,000.00
... . The Community Acquired Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Community Acquired Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
151 pages
Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Elephantiasis (Lymphatic Filariasis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Elephantiasis (Lymphatic Filariasis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
31 pages
